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Abstract 
Ambulatory blood pressure (BP) measurement (ABPM) is recommended to assess optimal BP 
control, we studied its influence after an acute type B aortic dissection (ATBAD).  
We retrospectively collected data from 111 patients with ATBAD from January 2004 to 
September 2014. Controlled BP group was defined according to a 24-hours BP under 
130/80mmHg during chronic phase. The population consisted of 85 males, with a mean age of 
61+/- 13 years and a mean body mass index of 28 +/-6 Kg/m². The median delay between 
ABPM and ATBAD was 2[0.3-4] months. The mean 24-hours BP of the entire population 
was 124/71 +/-15/8.8 mmHg. BP was not controlled in 41 patients (37%). The treatment score 
at discharge was 3.9+/-1.4. The mean glomerular filtration rate was 83 +/-28 mL/mn/1.73m², 
with no difference between groups. Visceral stent implantation in the acute phase (OR=3.857 
[1.199-12.406], p=0.023), higher left ventricular ejection fraction (OR=1.092 [1.005-1.187], 
p=0.038) and higher platelet count at discharge (OR=1.064 [1.018-1.112], p=0.006) were 
identified as predictors of good BP control by multivariate analysis. The analysis showed that 
night-time systolic BP was associated with aortic events during follow-up (HR=5.2 [1.01-
27.2], p=0.049), particularly for a threshold of 124 mmHg or more (HR=1.967 [1.052-3.678], 
p=0.0341). Nighttime pulse pressure showed also its significance (HR 20.1 [1.4-282.7], 
p=0.026). In conclusion, subclinical renal malperfusion revascularization seems to improve 
BP control. A higher night-time systolic BP was associated with the risk of new aortic events 
during follow-up. 
 
Keywords: Aortic dissection; blood pressure monitoring; renovascular hypertension; 
endovascular treatment. 
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Introduction 
Acute type B aortic dissection (ATBAD) is a rare but potential life-threatening vascular  
emergency and a complex disease to manage. Recent European guidelines state that 
endovascular techniques are the first line strategy in cases with complications [1]. ATBAD 
often occurs in patients presenting with the association of atherosclerosis and an old and 
poorly controlled hypertension[2]. Current guidelines on hypertension management 
recommend the use of ambulatory blood pressure (BP) measurement (ABPM)[3]. Since, 
ABPM is a better predictor of cardiovascular outcome than office BP[4]. In this retrospective, 
single center study, we assessed the prevalence and the impact of ABPM in the chronic phase 
of type B aortic dissection, as this important aspect is still unknown. 
 
Method 
We retrospectively collected data of all patients admitted for a first ATBAD between January 
2004 and September 2014 to cardiology intensive care unit. The acute nature of the aortic 
syndrome was defined by the onset of symptoms < 14 days to diagnosis. Penetrating aortic 
ulcer and iatrogenic or traumatic dissection were excluded from the study. Pre-hospital and 
in-hospital deaths were also excluded to assess only patients with a reasonable follow-up. 
At admission, the BP target to reach was 120/70 mmHg as recommended by the European 
guidelines of 2001[5]. In cases with evidence of impending rupture or end-organ ischemia 
endovascular management was favoured. Ranging from aortic fenestration (scissor technique) 
to aortic stent graft implantation and/or visceral (renal, celiac, superior mesenteric arteries) 
stenting[6-7].  Malperfusion syndrome presented as bowel, renal and/or lower limb clinical 
acute ischemia.  Blood investigations at admission and the day of discharge were incorporated 
into the statistical analysis.  
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The casual BP on the day of discharge was recorded. Then a 24 hours-ABPM (90207 monitor 
Spacelabs Healthcare, Snoqualmie, WA, USA) was performed. The cuff was placed on the 
right arm if the patient had an aortic stentgraft coveraging of the left subclavian artery. 
Daytime BP was defined between 6:00 am and 10:00 pm. “Dipper” status was defined as the 
presence of decreases in the BP values of more than 10% (compared with daytime values).  
Clinical BP was recorded at the time of the BP monitoring placement, and use of the various 
classes of antihypertensive medications taken at the time of the ABPM. A medication score 
(defined as the total number of antihypertensive medications taken by a patient) was recorded. 
The BP target to reach in the chronic phase was 135/80 mmHg at each consultation[1].  
All patients underwent Computed Tomography angiogram (CTA) imaging from the apex of 
the lungs to the femoral heads before discharge. CTA analysis was performed on a dedicated 
3D workstation (Aquarius, Terarecon, CA, USA). The true and false lumen diameters were 
measured at the level of the left pulmonary artery perpendicular to the line passing through 
the two insertion points of the intimal flap[8]. Left ventricular ejection fraction was estimated 
with Simpson’s rules. Left ventricle mass was measured according the American Society of 
Echocardiography and normalized against body surface area and against height 1.7[9].  
Follow-up and long-term information was obtained in May 2015. The primary end point was 
defined as a new aortic event (defined as a new dissection, aortic rupture or need to perform 
surgical or endovascular procedure after discharge) after discharge. All cause of death was 
defined as secondary endpoints.   
Quantitative variables are expressed as mean ±standard deviation in case of normal 
distribution or median (interquartile range) otherwise, and categorical variables are expressed 
as number (percentage). Normality of distributions was checked using the Shapiro-Wilk test. 
Patients were divided into two groups according to the level on ABPM at follow-up: 
controlled BP group (24-hour mean BP values < 130/80mmHg). 
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Bivariate comparisons between groups were made using Chi-square test (or Fisher’s exact test 
when the expected cell frequency was <5) for categorical variables and. In case of normal 
distribution Student t-test was used to compare quantitative parameters, otherwise Mann-
Whitney U-test was used. Variables associated with BP control (at p<0.20 in univariate 
analysis) were introduced in a multivariable logistic regression analysis; predictive power was 
evaluated using the c-statistics. 
Overall survival and aortic event-free probabilities were estimated using the Kaplan-Meier 
method, and between-group comparisons were done using the log-rank test. Under random 
censoring assumption, loss of follow-up were censored at last follow-up; for aortic event-free 
probabilities, patients died from non-aortic disease were also treated as censored events at 
time of death. As recommended, the duration shown on the curves was stopped if less than 
10% of the patients were still under follow-up[10]. Association of 24-BP values with all-
cause mortality and aortic events were assessed in univariable Cox models; results are 
reported as hazard ratio (HR) and predictive power was evaluated using the harrell's c 
statistic. If a significant association was established, a threshold value to best predict aortic 
event-free probabilities was determined using the algorithm of maximization of hazard ratio. 
Statistical testing was done at the two-tailed a level of 0.05 and data were analyzed using the 
SAS software package, release 9.4 (SAS Institute, Cary, NC). 
Results 
One hundred and fifty-three consecutive patients with first ATBAD were identified from 
hospital records. In-hospital mortality was 11% (n=17). Twenty five patients have no useful 
blood pressure monitoring data. Finally, our analysis on 111 patients with ABPM available 
for follow-up. The left ventricular ejection fraction was significantly higher in the BP 
controlled group (60% ± 5.9 vs 58% ± 5.1, p=0.0447). Demographics data and the 
cardiovascular risk factors are described in Table 1. 
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The median delay between discharge and ABPM measurement was 2[0.3-4] months with no 
difference between the 2 groups. The average treatment score was 3.9 ± 1.4 drugs per day 
with no difference between groups. The average clinical BP in all patients at discharge was 
controlled (128.8 mmHg ± 15.9 for the systolic, and 73.4 mmHg ± 12.5 for the diastolic). The 
systolic BP at discharge was significantly higher in the uncontrolled group compared with the 
controlled group (133 mmHg +/-13.9 vs 126.3 mmHg ± 16.5, p=0.036). The clinical BP at the 
time of ABPM was 131.1±18.8 mmHg for the systolic and 76.3±11.5 mmHg for the diastolic. 
The details of the ABPM data are listed in Table 2. 
The acute phase medical management is summarized in table 3. BP was better controlled in 
the group that received visceral/renal stent placement. Visceral stent implantation in the acute 
phase (OR=3.857 [1.199-12.406], p=0.023), higher LVEF (OR=1.092 [1.005-1.187], 
p=0.038) and higher platelet count at discharge (OR=1.064 [1.018-1.112], p=0.006) were 
demonstrated independently associated with successful BP control in multivariate analysis 
(Table 4) over a median follow-up period of 51[2-81] months. During follow-up, an aortic 
event occurred in 40 patients (38.7%) with a median delay of 23.5[9-51] months. In univariate 
Cox’s regression analysis, night time systolic BP was identified as a predictor of aortic events 
during follow-up (HR=5.2 [1.01-27.2], p=0.049). A threshold of 124mmHg was identified the 
best cut-off value to predict these events (HR=1.967 [1.052-3.678], p=0.0341) (Figure 1). The 
nighttime pulse pressure has a strong impact (HR=20.1 [1.4-282.7], p=0.026) on outcomes. 
Overall all-cause mortality at follow-up was 21% (n=22) with a median delay of 41[22-75] 
months. There was no significant association between the different BP data (BP at discharge, 
BP at consultation time, and all data of the ABPM) and the risk of death during follow-up.  
Discussion 
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Night time systolic BP is associated with an increased risk of aortic events during follow-up. 
The results show that endovascular revascularization of (visceral/renal) malperfusion syndrom 
is a strong predictor of BP control. 
As guidelines are targeting a low normal BP, we could have demonstrated earlier that 4.3 
drugs are necessary to reach the target BP[11]. The European Society of Hypertension define 
BP control as a mean BP of less than 130/80mmHg on the 24 hours ABPM. The ABPM 
thresholds were determined using the results of outcome studies such as the International 
Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO), as 
the Ohasama study, as the PAMELA study and as the Dublin study[12-13-14-15]. The 
threshold of 130/80 mmHg on ABPM corresponds to a BP threshold of 140/90 mmHg at 
consultation. In the management of chronic aortic syndrome, the European Society of 
Cardiology suggests a threshold of 135/80mmHg on office measurement[5]. Thus, the ideal 
target to reach with ABPM should be lower.  
Complications in the acute phase were recently defined by an expert consensus as 
malperfusion, hypertension associated with malperfusion or persisting despite full medical 
therapy, or increase in peri-aortic hematoma and hemorrhagic pleural effusion suggesting 
impending rupture[16]. In the special situation of resistant hypertension, early endovascular 
treatment has to be discussed. Indeed, data from IRAD suggest increased adverse outcomes in 
the acute phase for patients with resistant hypertension resulting in an increase in mortality 
mostly due to aortic rupture[17]. About 20 to 25% of individuals with ATBAS have a 
malperfusion syndrome with 10 to 15% of these involving renal arteries, which is an 
independent predictor of in-hospital mortality[18]. Renal malperfusion can be difficult to 
diagnose and can be underestimated[19]. Data from a series of spontaneous renal artery 
dissections presenting with severe hypertension report clinical success in treating 
hypertension by endovascular stent placement during long term follow-up[20]. The present 
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study cohort suggests a potential benefit of early endovascular treatment of malperfusion on 
successful blood pressure control in the chronic phase. Coagulation disorders have previously 
been described in the acute phase of aortic dissection and been shown to affect prognosis[21-
22]. Our study also suggests a relationship between platelet count and blood pressure control 
which could be explained by chronic inflammation induced by the dissection and false lumen 
activity, such conceptual thoughts however need more solid foundation.  
Finally, nighttime systolic BP appears to have a particularly important prognostic 
significance. Previous data suggest that night time systolic BP was the best predictor of 
cardiovascular events and mortality in patients with hypertension[12-13-23]. A higher systolic 
BP probably results from greater sympathetic activity[24]or greater  stiffness of the peripheral 
arterial system. Considering the results, it is also logical to speculate that similar finding can 
be observed in type A dissection patient. 
The limitations of this study include its retrospective design and single center data source, 
rendering it difficult to generalise our findings.  
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Figure Legends 
 
Figure 1 : Prognostic significance of systolic nighttime blood pressure on aortic events. 
Abbreviations : NTSB : nighttime systolic blood pressure 
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Table 1 : Baseline characteristics of the patients.  
 
Data are expressed by mean ± standard deviation. 
Variable          BP      controlled   
 Overall 
n=111 
Yes  
(n=70)  
No  
(n=41)  
p 
value 
Age (years) 
Female sex 
 
60.9 ± 12.9 
26 (23%) 
60.1 ± 12.5 
17 (24%) 
62.2 ± 13.6 
9 (22%) 
0.361 
0.779 
Smoker 
Hypertension  
Dyslipidemia 
Diabetes mellitus 
Body mass index (Kg/m)
2
  
Family history of CVD 
 
35 (31%) 
80 (72%) 
27 (24%) 
11 (10%) 
28.4 ± 6.2 
12 (11%) 
22 (31%) 
44 (63%) 
14 (20%) 
10 (14%) 
28.6 ± 6.3 
5 (7%) 
13 (32%) 
36 (88%) 
13 (32%) 
1 (2%) 
28.2 ± 6 
7 (17%) 
0.976 
0.005 
0.165 
0.051 
0.839 
0.119 
Prior atherosclerosis and cardiovascular 
disease 
Prior thoracic aortic aneurysm 
Prior type A aortic dissection 
Prior cardiac surgery 
Atrial fibrillation 
Connective tissue disease 
14 (13%) 
8 (7%) 
3 (3%) 
10 (9%) 
9 (8%) 
11 (10%) 
7 (6%) 
8 (11%) 
7 (10%) 
2 (3%) 
7 (10%) 
7 (10%) 
8 (11%) 
6 (9%) 
 
6 (15%) 
1 (2%) 
1 (2%) 
3 (7%) 
2 (5%) 
3 (7%) 
1 (2%) 
0.623 
0.254 
NA 
0.742 
0.481 
0.744 
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Abbreviations : BP : blood pressure. CVD : cardiovascular disease. ECG : electrocardiogram. LVEF : left 
ventricular ejection fraction. LVM : left ventricular mass. NA : not applicable. 
 
Prior cardiovascular disease : peripheral arterial disease, coronary artery disease or aortic aneurysm. 
Tobacco use : current smoking or stopped from less than 3 years. 
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Table 2 : 24-hours blood pressure measurement data. 
 
Data are expressed by mean ± standard deviation and median (interquartile range) 
Abbreviations : ACE inhibitor : angiotensin-converting-enzyme inhibitor. ARB : angiotensin-receptor 
blocker. BP : blood pressure. bpm : beats per minute. DBP : diastolic blood pressure. HR :heart rate. 
SBP : systolic blood pressure. VKA : vitamin K antagonist. NA : not applicable. 
Variable               BP Controlled    
 Overall 
n=111 
Yes  
 (n=70)  
NO 
(n=41)  
p value 
24-h SBP (mmHg) 
 
24-h DBP (mmHg) 
 
24-h PP  (mmHg)  
 
24-h HR (bpm) 
 
Daytime SBP (mmHg) 
 
Daytime  DBP (mmHg) 
 
Daytime  PP (mmHg) 
 
Daytime  HR  (bpm) 
 
Nighttime SBP (mmHg) 
 
Nighttime  DBP (mmHg) 
 
Nighttime  PP (mmHg) 
 
Nighttime  HR (bpm) 
 
Dipping status 
124 ± 15 
 
71 ± 9 
 
53 ± 11 
 
68± 10 
 
125 ± 15 
 
72 ± 9 
 
53 ± 11 
 
69± 11 
 
121± 18 
 
69 ± 10 
 
53± 12 
 
65± 11 
 
33 (30%) 
115 ± 9 
 
67 ± 6 
 
48± 9 
 
66 ± 10 
 
117 ± 10 
 
68 ± 7 
 
48± 9 
 
68 ± 11 
 
112 ± 12 
 
64 ± 7 
 
48± 10 
 
64 ± 10 
 
25 (36%) 
140 ± 10 
 
78 ± 8 
 
61± 10 
 
70 ± 10 
 
140 ± 10 
 
79 ± 8 
 
61± 10 
 
72 ± 10 
 
138± 13 
 
77 ± 10 
 
61 ± 11 
 
68± 10 
 
8 (20%) 
< 0.001 
 
< 0.001 
 
< 0.001 
 
0.052 
 
 < 0.001 
 
< 0.001 
 
< 0.001 
 
0.057 
 
< 0.001 
 
< 0.001 
 
< 0.001 
 
0.042 
 
0.072 
     
     
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Variable                    BP Controlled   
 Overall 
n=111 
Yes 
(n=70) 
    NO 
  (n=41) 
p 
value 
Pharmacotherapy at discharge     
Beta-blocker 
ACE inhibitor 
ARB 
Calcium-channel blocker 
Antialdosterone 
Thiazide diuretic 
Treatment score 
107 (96%) 
78 (70%) 
22 (20%) 
97 (87%) 
32 (29%) 
55 (49%) 
3.9 ± 1.4 
67 (96%) 
49 (70%) 
12 (17%) 
60 (86%) 
17 (24%) 
31 (44%) 
3.8 ± 1.4 
40 (98%) 
29 (71%) 
10 (24%) 
37 (90%) 
15 (37%) 
24 (58%) 
4.1 ± 1.3 
NA 
0.935 
0.355 
0.488 
0.167 
0.147 
0.143 
     
Endovascular procedure 48 (43%) 34 (49%) 14 (34%) 0.14 
Aortic endograft 
Fenestration 
Visceral artery stenting 
 
31 (28%) 
7 (6%) 
26 (23%) 
20 (28%) 
5 (7%) 
21 (30%) 
11 (27%) 
2 (5%) 
5 (12%) 
0.81 
NA 
0.032 
Early aortic complications     
Malperfusion syndrome 
   Bowel ischemia 
   Renal ischemia 
   Lower limb ischemia 
Impending aortic rupture 
40 (36%) 
13 (12%) 
24 (22%) 
13 (12%) 
11 (10%) 
26 (37%) 
10 (14%) 
18 (26%) 
7 (10%) 
8 (11%) 
14 (34%) 
3 (7%) 
6 (15%) 
6 (15%) 
3 (7%) 
0.75 
0.37 
0.17 
0.55 
0.74 
At discharge     
GFR (mL/mn/1.73m² ) 
Platelet count ( /mm3 ) 
83.7 ± 28.2 
329 000 ± 
83.6 ± 28.9 
352 000 ± 116 000 
83.9 ± 27.2 
289 000 ± 
0.95 
0.006 
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Table 3 : In-hospital management, biological and morphological data at discharge. 
Data are expressed by mean ± standard deviation. 
 
Abbreviations : ACS : acute coronary syndrome. BP : blood pressure. GFR: glomerular filtration rate.  
 
NA: not applicable 
 
 
LDL cholesterol (mg/dl) 
 
113 000 
104 ± 36  
 
 
99 ± 39 
 
94 267 
 
116 ± 30 
 
 
0.002 
Ascending aorta  diameter 
(mm) 
Thoracic descending aorta 
diameter (mm) 
False lumen diameter (mm) 
 
36 ± 4.8 
37.3 ± 6.2 
19.9 ± 7.8 
 
36.6 ± 4.7 
37.7 ± 6.4 
20.1 ± 8.2 
 
35 ± 4.8 
36.7 ± 5.8 
19.7 ± 7 
 
0.105 
0.504 
0.814 
False lumen status      
Complete thrombosis 
Partial thrombosis, 
Patent 
Not analysable 
7 (6%) 
38 (34%) 
51 (46%) 
15 (14%) 
4 (6%) 
22 (31%) 
34 (49%) 
10 (14%) 
3 (7%) 
16 (39%) 
17 (42%) 
5 (12%) 
NA 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Table 4: Multivariate analysis predicting good blood pressure control 
 
Abbreviations : CI : confidence interval. LVEF : left ventricular ejection fraction. OR : odds ratio.  
 
C-statistics (CI 95%)= 0.74 (0.64-0.83) 
 
Variable Units OR [CI 95%] p value 
Visceral artery stenting 1 3.857 [1.199-12.406] 0.024 
Platelet count at discharge 10 000 1.064 [1.018-1.112] 0.006 
LVEF 1 1.092 [1.005-1.187] 0.038 
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